DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Cognetix
Salt Lake City, UT
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.